Style de citation APA (7e éd.)

Klavdianou, K., Melissaropoulos, K., Filippopoulou, A., & Daoussis, D. (2021). Should we be Afraid of Immune Check Point Inhibitors in Cancer Patients with Pre-Existing Rheumatic Diseases? Immunotherapy in Pre-Existing Rheumatic Diseases. PCO Convin S.A.

Style de citation Chicago (17e éd.)

Klavdianou, Kalliopi, Konstantinos Melissaropoulos, Alexandra Filippopoulou, et Dimitrios Daoussis. Should We Be Afraid of Immune Check Point Inhibitors in Cancer Patients with Pre-Existing Rheumatic Diseases? Immunotherapy in Pre-Existing Rheumatic Diseases. PCO Convin S.A, 2021.

Style de citation MLA (8e éd.)

Klavdianou, Kalliopi, et al. Should We Be Afraid of Immune Check Point Inhibitors in Cancer Patients with Pre-Existing Rheumatic Diseases? Immunotherapy in Pre-Existing Rheumatic Diseases. PCO Convin S.A, 2021.

Attention : ces citations peuvent ne pas être correctes à 100%.